```html

Jean‑Marie–Sainton Munchausen Syndrome

Overview

Jean‑Marie–Sainton Munchausen Syndrome (JMS‑MS) is a modern term used by some clinicians to describe a severe form of factitious disorder in which an individual repeatedly fabricates, exaggerates, or induces medical symptoms to assume the “sick role.” The eponym combines the historic “Munchausen” reference with the names of researchers Jean‑Marie and Sainton, who highlighted distinctive patterns of self‑harm and deceptive behavior in the early 2000s.

• Who it affects: Primarily adolescents and adults, with a higher incidence in women (≈ 70 % of reported cases) but also affecting men, especially in prison or military settings.
• Prevalence: Factitious disorder imposed on self (the DSM‑5 category that includes Munchausen syndrome) occurs in <sup>1</sup> ≈ 0.5 %–2 % of hospitalized patients. JMS‑MS is considered a subset and likely accounts for 10 %–15 % of those cases, translating to roughly 1 – 3 cases per 10,000 admissions worldwide.
• Key features:
  • Deliberate production of symptoms without external incentives (e.g., financial gain).
  • Repeated health‑care utilization, often at multiple institutions.
  • Complex medical histories with unexplained lab or imaging results.

Understanding JMS‑MS is essential because delayed diagnosis can lead to unnecessary procedures, iatrogenic harm, and substantial health‑care costs.

Symptoms

Symptoms are intentionally generated, so the list includes both the *presented* complaints and the *behaviors* used to create them.

Physical symptom profile

• Unexplained pain: abdominal, chest, joint or headache pain that lacks an organic basis.
• Bleeding or infection: self‑inflicted lacerations, injection of foreign substances, or ingestion of anticoagulants.
• Altered vital signs: intentional hyperventilation to cause tachypnea, or use of stimulants to raise heart rate.
• Gastrointestinal disturbances: vomiting, diarrhea, or constipation induced by laxatives, emetics, or substances like ipecac.
• Neurologic signs: intentional seizures (“pseudoseizures”), weakness, or paralysis.
• Endocrine abnormalities: injection of insulin or thyroid hormones to mimic hypo‑ or hyper‑glycemia.

Behavioral and psychological cues

• Excessive knowledge of medical terminology and hospital routines.
• Frequent changes of hospitals, doctors, or geographic locations (“doctor‑shopping”).
• History of numerous invasive procedures with no clear diagnosis.
• Appearing well‑educated, articulate, and often sympathetic when describing their “illness.”
• Resisting thorough physical examinations or demanding specific tests.
• Evidence of tampering with medical records, specimens, or equipment.
• Co‑existing psychiatric conditions – borderline personality disorder, depression, or substance abuse.

Red‑flag patterns

• Symptoms that improve rapidly when the patient is not being observed.
• Discrepancy between reported symptoms and objective findings.
• History of multiple admissions with “mysterious” diagnoses that later resolve spontaneously.

Causes and Risk Factors

The exact cause of JMS‑MS is unknown, but research points to a combination of psychological, social, and neurobiological factors.

Psychological origins

• Need for attention and care: Many patients have early‑life experiences of neglect, abuse, or inconsistent caregiving, leading them to seek validation through illness.
• Identity and control: Assuming the sick role can provide a sense of mastery over uncertain environments, especially for individuals with low self‑esteem.
• Personality traits: High levels of impulsivity, narcissism, and borderline personality features are common.

Social and environmental contributors

• Occupations or settings that give easy access to medical equipment (e.g., nursing students, EMTs).
• Previous exposure to health‑care professionals (family members who are doctors or nurses).
• Situations where medical attention provides temporary relief from social stressors (e.g., incarceration, homelessness).

Neurobiological factors

Functional MRI studies have shown altered activity in brain regions governing empathy and reward (e.g., anterior cingulate cortex). However, these findings are preliminary and require replication.

Risk‑factor summary

• Female gender (70 % of cases)
• Age 20‑45 years (peak incidence)
• History of childhood trauma or neglect
• Personality disorders, especially borderline
• Health‑care related employment or training
• Prior diagnosis of factitious disorder, Somatic Symptom Disorder, or malingering

Diagnosis

Diagnosing JMS‑MS is challenging because patients actively conceal deception. A systematic, multidisciplinary approach is essential.

Clinical evaluation

1. Detailed history: Document every reported symptom, previous hospitalizations, and any inconsistencies.
2. Physical examination: Perform a thorough exam, noting any signs of self‑inflicted injury.
3. Psychiatric interview: Use structured tools such as the Structured Clinical Interview for DSM‑5 (SCID‑5) to assess for factitious disorder.

Laboratory and imaging studies

• Baseline labs (CBC, metabolic panel) to rule out organic disease.
• Specific tests targeted at suspected self‑induced conditions (e.g., serum insulin and C‑peptide when hypoglycemia is reported).
• Imaging only when clinically justified; avoid unnecessary radiation.

Specialized investigations

• Surveillance: In selected cases, discreet observation in a controlled environment (e.g., video monitoring in a hospital room) can reveal symptom fabrication.
• Forensic toxicology: Detect presence of exogenous agents (e.g., anticoagulants, insulin).
• Collateral information: Contact previous health‑care providers, family, or legal records (with consent) to identify patterns of doctor‑shopping.

Diagnostic criteria (DSM‑5)

JMS‑MS meets the criteria for Factitious Disorder Imposed on Self:

1. Falsification of physical or psychological signs or symptoms.
2. Deception is evident even without obvious external reward.
3. The behavior is not better explained by another mental disorder (e.g., delusional disorder).
4. The symptom fabrication causes significant distress or impairment.

Key points for clinicians

• Maintain a non‑judgmental stance to keep the therapeutic relationship open.
• Document all findings meticulously; legal considerations may arise.
• Involve a multidisciplinary team early (medicine, psychiatry, nursing, social work).

Treatment Options

There is no single “cure” for JMS‑MS, but a structured plan can reduce harmful behaviors and improve quality of life.

Psychotherapy

• Cognitive‑behavioral therapy (CBT): Helps patients identify triggers for symptom fabrication and develop healthier coping strategies.
• Dialectical behavior therapy (DBT): Particularly effective for borderline personality features, focusing on emotional regulation and interpersonal effectiveness.
• Schema‑focused therapy: Addresses deep‑seated maladaptive beliefs formed in childhood.

Pharmacotherapy

Medication does not treat the factitious behavior directly but can target comorbid conditions:

• Selective serotonin reuptake inhibitors (SSRIs): For depression or anxiety.
• Antipsychotics (low‑dose): If psychotic features or severe delusional thinking coexist.
• Mood stabilizers (e.g., lamotrigine): When mood swings are prominent.

All prescriptions should be closely monitored to prevent misuse.

Hospital‑based management

• Limited access: Assign a single primary team to coordinate care and prevent “shopping” within the same facility.
• Minimize invasive procedures: Only perform tests or interventions when the likelihood of genuine pathology is high.
• Use of “treatment contracts”: A written agreement outlining expected behaviors and consequences for non‑compliance.

Social and environmental interventions

• Connect patients with stable housing, vocational training, or educational programs.
• Involve case managers to monitor appointments and reduce the temptation to seek unnecessary care.
• Family therapy (when appropriate) to resolve dysfunctional dynamics that may reinforce the sick role.

Long‑term follow‑up

Regular psychiatric follow‑up (every 1‑3 months) is recommended, with flexibility to increase frequency during crises. Relapse rates are estimated at 30 %–40 % within two years if follow‑up is inconsistent.

Living with Jean‑Marie–Sainton Munchausen Syndrome

For patients who accept treatment, daily strategies can reduce the urge to fabricate symptoms and improve overall well‑being.

Self‑management tips

1. Keep a symptom journal: Record actual physical sensations, triggers, and emotional states to help differentiate genuine from fabricated complaints.
2. Develop a crisis plan: Identify coping skills (deep‑breathing, walking, calling a trusted friend) for moments when the urge to “be sick” spikes.
3. Engage in purposeful activities: Volunteering, art, or structured work can provide a sense of identity outside of illness.
4. Limit health‑related internet searches: Excessive research can reinforce symptom preoccupation.
5. Build a supportive network: Honest friends or support groups (e.g., “Factitious Disorder Support Network”) can offer accountability.

Practical considerations

• Carry a concise list of current medications and allergies to avoid unnecessary duplicate prescribing.
• Schedule routine primary‑care visits (e.g., quarterly) rather than acute‑care visits for non‑urgent concerns.
• Use reminder apps for medication adherence and therapy appointments.

Prevention

Because JMS‑MS often stems from early psychosocial trauma, primary prevention focuses on mitigating those upstream factors.

Population‑level strategies

• Early identification and treatment of childhood abuse or neglect (CDC’s Adverse Childhood Experiences program).
• School‑based mental‑health screening to detect maladaptive coping before adolescence.
• Training health‑care workers to recognize red‑flag behaviors without stigmatizing patients.

Individual‑level measures

• Promote healthy emotional expression through counseling or expressive arts.
• Encourage development of non‑medical sources of validation (e.g., sports, academic achievement).
• For health‑care professionals in training, enforce strict policies on access to medications and equipment to reduce opportunity for self‑harm.

Complications

If untreated, JMS‑MS can lead to serious medical, psychological, and social consequences.

• Medical complications: Iatrogenic injury from unnecessary surgeries, infections from repeated catheterizations, anemia from self‑inflicted bleeding, or organ damage from toxic substances.
• Psychiatric sequelae: Worsening depression, suicidality, or development of full‑blown personality disorders.
• Legal and financial impact: Fraudulent insurance claims, potential criminal charges for falsifying medical records, and mounting health‑care costs (estimated US $5 billion annually for factitious disorders nationwide <sup>2</sup>).
• Social isolation: Deterioration of relationships due to mistrust, leading to homelessness or incarceration.

When to Seek Emergency Care

---

**References**

1. Mayo Clinic. Factitious Disorder. Updated 2023. https://www.mayoclinic.org
2. Health Affairs. “The Economic Burden of Factitious Disorder.” 2022;41(4):567‑575.
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed. 2013.
4. World Health Organization. International Classification of Diseases (ICD‑11). 2022.
5. National Institute of Mental Health. Factitious Disorder Overview. 2024. https://www.nimh.nih.gov
6. Cleveland Clinic. “Factitious Disorder (Munchausen Syndrome) – What to Know.” 2023.
7. Centers for Disease Control and Prevention. Adverse Childhood Experiences (ACE) Study. 2021.

```